How adequate are the new guidelines on clinical evaluation of bacteriological outcome in uncomplicated UTI?

International Journal of Antimicrobial Agents

Volumn 11, Issue 3-4, 1999, Pages 183-184

  Norrby, S R ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bacteriuria; Clinical evaluation; Urinary tract infection

Indexed keywords

NORFLOXACIN; RITIPENEM ACOXIL;

ADULT; BACTERIAL COUNT; BACTERIURIA; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTITIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PYURIA; TREATMENT FAILURE; TREATMENT OUTCOME; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; CLINICAL TRIALS; CYSTITIS; EVALUATION STUDIES; FEMALE; GUIDELINES; HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); URINARY TRACT INFECTIONS;

EID: 0032928870     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(99)00042-4     Document Type: Conference Paper

References (2)

1. The Swedish Urinary Tract Infection Study Group. Interpretation of the bacteriologic outcome of antibiotic treatment for uncomplicated cystitis: Impact of the definition of significant bacteriuria in a comparison of ritipenem acoxil with norfloxacin. Clin Infect Dis 1995;20:507-13.
2. Kunin CM. Guidelines for the evaluation of new anti-infective drugs for the treatment of urinary tract infections: additional considerations. Clin Infect Dis 1992;15:1041-4.